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INTRODUCTION 
Osteoarthritis (OA) and the diagnosis 
OA is a degenerative joint disease which alters the structure of 
the cartilage. The thickness of the cartilage diminishes and the 
adjacent structures, i.e. synovial membrane, menisci and underly-
ing bone, are also affected. In time, OA causes pain, lowers physi-
cal function and ultimately leads to a reduced quality of life.[2] In 
OA research, two possibly interacting views govern the field, 
namely a biomechanical view, where altered loading patterns of 
the joint are thought to cause additional wear to the cartilage, 
and a systemic view, where inflammation is the driving factor 
behind cartilage degeneration.[5-10] For the clinician, however, 
OA may be better defined by its two cardinal symptoms, i.e. pain 
and functional loss, or by its pathology such as radiographic 
changes, Figure 1. 
 
 
OA symptoms Traditionally, a medical history of the patient´s 
symptoms, severity and duration is obtained through a semi-
structured interview (anamnesis) led by a health care profession-
al. Through this, an overall, however possibly subjective, idea of 
the patient´s illness is obtained. To facilitate interpretation of the 
patient´s response, great focus has been placed on the develop-
ment of patient self-reported questionnaires over the last two 
decades. In the clinical setting, symptom severity may be evaluat-
ed by disease-specific questionnaires, examples of which include 
the Oxford Knee Score (OKS) or the Knee Injury and Osteoarthritis 
Outcome Score (KOOS) and the Oxford Hip Score (OHS) or Hip 
Osteoarthritis Outcome Score (HOOS) for patients with knee or 
hip OA respectively. Here, the challenge lies in defining cut points 
for disease severity based on the score derived from the ques-
tionnaire.[11] 
OA pathology In the early stages of the degenerative process, 
pathological changes are detectable by means of biomarkers; i.e. 
molecular fragments measured in patient’s plasma. However, 
biomarkers have not attained a position in the clinical setting to 
secure diagnosis. In mild OA, the thinning of joint cartilage and its 
effect on underlying bone may be visualised by magnetic reso-
nance (MR) scanning. This highly detailed modality is appreciated 
by many clinicians but is costly and time-consuming. More ad-
vanced OA can be seen as radiographic features, i.e. osteophytes, 
joint space narrowing and sclerosis of subchondral bone. The 
radiological severity of OA may be evaluated through various 
classification systems.[12-14] Defining severity of the disease is 
challenging. Generally, joint space narrowing and subchondral 
sclerosis are accepted as signs of more progressive disease.[15, 
16] Throughout the OA literature, the Kellgren & Lawrence meth-
od (KL) is most commonly used. Radiographic changes are graded 
from 1 to 4 with severe joint space narrowing and marked sub-
chondral sclerosis being present in grade 4.[12] 
As illustrated in Figure 1, the diagnosis of OA is not always 
straightforward since patients with symptoms of OA may not 
necessarily display radiographic features of the disease and vice 
versa.[17-20] The discrepancy often found between symptom and 
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radiographic severity may influence and further challenge the 
decision-making about what treatment to offer the patient.[21] 
Today, the diagnosis may be based on symptoms and clinical 
evaluation only.[22] 
 
Magnitude and burden of OA 
OA patients not only suffer from pain, physical disability and 
reduced quality of life, but also display an increased risk of prem-
ature death most likely due to the sedentary and inactive lifestyle 
the disease imposes on the individual.[23] At a societal and 
worldwide level, OA has major implications. The disease gener-
ates a heavy burden equivalent to that of diabetes and ranks 
eighth in the leading causes of disability worldwide.[24-26]  The 
prevalence of OA increases with age and 10-18% of people aged 
above 60 years are affected.[27] In the United States (US) alone, 
67 million people (25%) are expected to be diagnosed with an 
arthritic condition by the year 2030 with OA being the major 
contributor.[28] People who are overweight have a higher preva-
lence of OA[2, 29]. Furthermore, the risk of symptomatic and 
radiographic progression is closely related to obesity.[30, 31] 
With the ageing of the population in combination with life-styles 
yielding obesity and physical inactivity, the future burden of OA 
will increase.[26, 32] 
Few studies have investigated the economic impact of OA.[33] An 
estimate from an American population puts the total annual costs  
of OA in the US at $89.1 billion.[34] This figure is based on both 
direct costs, e.g. medication, physical therapy and hospitalisation 
and indirect costs, e.g. home care and absence from work. Alt-
hough more prevalent in the elderly population, OA also affects 
younger people still working, with the median age of diagnosis 
estimated to be 55 years.[35] Work disability is significantly high-
er in the OA population.[36] In the US, costs are estimated to be 
$8.3 billion due to job-related OA alone.[34] In general, with the 
increase in affected individuals, the overall costs associated with 
the disease will inevitably increase.[37-39] 
 
Treatment options 
Currently, there is no cure for OA and the various treatment 
modalities aim at addressing symptoms, i.e. to reduce pain, to 
improve physical function and to prevent further progression of 
the disease. End-stage OA is successfully treated with joint ar-
throplasty. Treatment falls into one of three categories: first line, 
pharmacological and surgical, Figure 2. 
 
 
 
First line treatment for OA 
Modalities in this category are various and some multi-faceted. 
Current guidelines recommend patient education, weight loss, 
orthoses and exercise.[22, 40-42] Patient education is considered 
a core element in treating OA and aims at providing basic infor-
mation about the disease, enhancing empowerment and self-
management. A meta-analysis for both hip and knee patients 
demonstrates small (0.06, 95% CI 0.02, 0.10) but statistically 
significant effect sizes for patient education in reducing pain and 
self-reported activity limitation.[41] It can of course be ques-
tioned if other outcomes such as improved decision-making and 
reduced anxiety would be more appropriate outcomes than pain 
reduction and functional improvement. Patient education can be 
delivered in different settings[43, 44] and with various con-
tent[45, 46], however, no optimal programme has been identified 
for patients with OA.[47]  
In patients with knee OA, the effectiveness of weight loss pro-
grammes on body weight, pain and/or physical function has been 
demonstrated, typically, in programmes delivered weekly as 
supervised sessions for a range of 8 weeks to 2 years.[48-52] The 
effects on pain and function from attending weight loss pro-
grammes are overall small, but significant (ES pain 0.20, 95% CI 
0.00 to 0.39; ES physical function 0.23, 95% CI 0.04 to 0.42).The 
intervention strategies generally include advice on how to reduce 
calorie intake and comprise behavioral modification, self-
monitoring, goal setting, and some include exercise. 
Exercise is proven effective for reducing pain and improving phys-
ical function in patients with mild to moderate radiographic knee 
OA (K+L score 1-2).[53, 54] This association is not as well docu-
mented for hip OA.[43, 55-57] For knee OA, the effects of exer-
cise are small to moderate and significant for pain reduction (ES 
0.40, 95% CI 0.30 to 0.50) and improvement in physical function 
(ES 0.37, 95% CI 0.25 to 0.49). The exercise interventions applied 
in OA research are heterogeneous which makes comparison 
across studies challenging.[53, 55] These interventions generally 
fit into one of three categories: strength, aerobic or mixed inter-
ventions.[58] The neuromuscular training method applied in this 
dissertation belongs in the category of mixed interventions with 
components of aerobic exercise, muscle strength training, func-
tional alignment and core stability.[59] Strengthening exercise 
training is exercise that causes muscles to work or hold against an 
applied force or weight.[60] These may comprise handling of own 
body weight in various positions or exercises where external 
loads, e.g. free weights and weight stacks on resistance exercise 
equipment, are applied. Strengthening exercise aims at improving 
muscle strength which is a known deficit associated with OA.[61, 
62] Resistance training programmes emphasising dynamic exer-
cises involving concentric (shortening) and eccentric (lengthening) 
movements that recruit multiple muscle groups are recommend-
ed.[59] For patients with knee OA, both specific quadriceps 
strengthening exercises or strength training for the lower limb in 
general are effective in reducing pain (ES, 95% CI: 0.29, 0.06 to 
0.51 and 0.53, 0.27 to 0.79, respectively) and improving physical 
function (ES, 95% CI: 0.24, 0.06 to 0.42 and 0.58, 0.27 to 0.88, 
respectively).[63] Aerobic exercise training refers to exercises in 
which the body’s large muscles move in a rhythmic manner for 
sustained periods.[60] It generally aims at improving cardiovascu-
lar function, e.g. oxygen uptake, and metabolic status such as 
glycemic control but may furthermore improve range of move-
ment. Various training methods can be used, e.g. cycling, walking, 
swimming, etc. Most OA studies evaluating aerobic exercise have 
focused on walking. In patients with knee OA, aerobic training 
(walking) is effective in reducing pain (ES, 95% CI: 0.48, 0.13 to 
0.43) and improving physical function (ES, 95% CI: 0.35, 0.11 to 
0.58).[63] Neuromuscular exercise programmes aim at improving 
sensorimotor control and achieving compensatory functional 
stability. Functional, weight-bearing and land-based exercises are 
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used in various positions, resembling conditions of daily life and 
more strenuous activities. The quality of the performance in each 
exercise is emphasised and the level of training and progression is 
guided by the patient's neuromuscular function evaluated by the 
supervising physiotherapist.[64] The evidence for mixed exercise 
programmes including strengthening, aerobic and flexibility com-
ponents in patients with mild to moderate knee OA is conflict-
ing.[58, 63, 65] However, one meta-analysis demonstrates effect 
sizes for knee pain (ES,95% CI: 0.4, 0.30 to 0.50) and self-reported 
physical function (ES,95% CI: 0.37, 0.25 to 0.49).[53] Tailored 
neuromuscular exercise training programmes have positive ef-
fects in younger patients with anterior cruciate ligament injury, 
they improve cartilage glycosaminoglycan content and physical 
function in middle-aged people at risk of OA[66, 67]and are found 
feasible and safe for patients with severe OA.[64] However, no 
randomised controlled trials in the OA literature evaluating the 
effects of specified neuromuscular exercise were found. 
Today, no one category of exercise has been demonstrated to be 
superior to another in patients with OA.[58, 63, 65] However, a 
very recent systematic review suggests that focusing on one 
category is more effective than mixed interventions and super-
vised exercise is favorable to unsupervised.[68] Twelve or more 
directly supervised sessions have been shown to be more effec-
tive than less than 12 sessions on pain (ES 0.46, 95% CI 0.32 to 
0.60 versus ES 0.28, 95% CI 0.16 to 0.40, p=0.03) and physical 
function (ES 0.45, 95% CI 0.29 to 0.62 versus ES 0.23, 95% CI 0.09 
to 0.37, p=0.02).[63] 
 
Pharmacological treatment 
Pain is a cardinal symptom of OA and, together with reduced 
physical function, is the main reason for this patient group seek-
ing professional health care. Hence, much focus is placed on 
relieving pain. The effects of pharmacological treatment on OA 
come from studies evaluating patients with knee OA or studies 
where hip or knee OA patients were evaluated as one group and 
no stratified analysis was made on the basis of the affected joint. 
Pharmacological treatment alongside first line treatment is rec-
ommended as optimal management of mild to moderate OA.[40, 
41, 69] Acetaminophen (paracetamol) in doses of up to 4 g/day is 
today considered first-line pharmacological treatment.[41, 70]  
For knee OA, it demonstrates small effects on pain reduction (ES, 
95% CI: 0.13, 0.04 to 0.22) and no effect on physical function (ES, 
95% CI: 0.09, -0.03 to 0.22).[71, 72] When acetaminophen does 
not offer satisfactory pain relief, the use of non-steroidal anti-
inflammatory drugs (NSAIDs) is recommended.[41, 42] NSAIDs 
can be delivered orally or topically with varying effects (ES, 95% 
CI: 0.29, 0.22 to 0.35 vs. 0.44, 0.27 to 0.62) for knee pain.[41] 
Although displaying a superior effect to acetaminophen (ES, 95% 
CI: 0.20, 0.10 to 0.30)[73], oral NSAIDs are associated with serious 
side effects, e.g. gastro-intestinal (GI) ulcers and bleeding[74], 
and results in more frequent GI hospitalisation.[75] NSAIDs are 
available as selective cyclooxygenase (Cox) -2 inhibitors shown to 
have fewer GI side effects compared with non-selective 
NSAIDs[75], however, more frequently displaying cardiovascular 
side effects, e.g. myocardial infarction.[74] No differences in GI 
side effects are found between selective and non-selective 
NSAIDs when administered in combination with a proton pump 
inhibitor.[76] Paracetemol and NSAIDs may be given in combina-
tion and a recent randomised trial reported greater short-term 
pain relief from combined administration than paracetamol and 
ibuprofen alone.[77] However, the combination seems to in-
crease the risk of GI hospitalisation.[75] 
Opioids offer large reduction in pain intensity (ES, 95% CI : 0.78, 
0.59 to 0.98), but the effect is outweighed by the numerous side 
effects, e.g. nausea and dizziness.[41] 
As treatment for OA, the use of glucosamin, a natural constituent 
of cartilage, is thought to stimulate regeneration of cartilage and 
reduce pain. Although recommended in six of the ten guidelines, 
evidence is rather conflicting and much debated.[41, 78]  
 
Surgical treatment 
Where first line and second line treatment fails to alleviate 
pain and physical dysfunction, surgery constitutes a viable treat-
ment option. Total joint arthroplasty (TJA) is recognised as an 
effective pain relief and a relatively safe and cost-effective treat-
ment in patients with severe OA of the hip or knee joint.[79] 
Millions of TJA procedures are performed annually worldwide. 
The exact number is unknown but one study reports a crude 
incidence rate for total hip arthroplasty (THA) of 119 per 100,000 
persons per year and a little lower for total knee arthroplasty 
(TKA).[80] The variation, however, is great between wealthier and 
poorer countries, e.g. in Austria, the age-standardised incidence 
rate is 266.2 (95% CI 269.7 to 273.3) per 100,000 and in Romania 
35.4 (95% CI 36.3 to 37.1) being the highest and lowest, respec-
tively.[80] The rates are increasing and have been for the past 
two decades, as illustrated for Denmark in Figure 3. 
 
 
   
After surgery, patients generally experience significant reduc-
tion in pain, and improvement in self-reported physical function 
and health-related quality of life.[81-83] The greatest improve-
ments are reported at 6-12 months after surgery.[84, 85] As for 
pharmacological treatment, there seems to be differences in 
response to THA and TKA.[86]Very few studies have made direct 
comparison between the two. TKA patients may display faster 
short-term recovery (6 to 9 weeks post-surgery) in physical func-
tion, but this is surpassed by THA patients at 9 to 11 weeks.[87] 
However, in general, THA patients report higher improvement in 
pain reduction, physical function, quality of life and tend to be 
more satisfied with the procedure.[81, 83, 86] Overall, patients 
report general satisfaction although their pre-operative expecta-
tions are not always fulfilled.[81, 85, 88, 89] Various studies have 
been conducted to evaluate predictors of a successful TJA proce-
dure and patient satisfaction.[84, 90-98] In general, high expecta-
tions, high level of pre-operative pain and older age are associat-
ed with a poorer outcome. Socioeconomic factors, e.g. years 
attending school, employment and disability pension, are inde-
pendent predictors of post-operative outcome.[91] Although 
regarded as successful procedures, there are still challenges to 
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overcome in this patient group; some do not respond to treat-
ment[90] and have persistent pain[85] and THA patients never 
reach the level of physical function of healthy controls[99], Figure 
4. 
 
 
The decision as to when to offer TJA surgery is influenced by 
many factors, e.g. pain severity, level of physical disability, age 
and sex.[100, 101] As of today, no specific cut-off or severity state 
is found to determine an indication for surgery.[21, 102] 
Two other surgical procedures serve as alternative treatment 
options for a selected group of patients with knee OA, i.e. tibial-
osteotomy and uni-compartmental joint arthroplasty. These will 
not be considered in this dissertation. 
 
PRE-OPERATIVE EXERCISE 
Exercise treatment (pre- or post-operative) is incorporated in the 
umbrella term ‘rehabilitation’, defined as treatments designed to 
facilitate the process of recovery from injury, illness, or disease to 
as normal a condition as possible. In relation to TJA, it has tradi-
tionally been practised after surgery with a focus on restoring 
activities of daily living (ADL) and physical fitness. Reports on the 
efficacy and feasibility were published in the early years of joint 
arthroplasty surgery.[103-106] Accelerated perioperative care or 
Fast Track Surgery, where patient information, procedures and 
rehabilitation associated with TJA are optimised, has gained 
ground over the last decade. It has reduced costs and length of 
hospital stay[107-109] and is now considered standard care. Post-
operative rehabilitation is the general approach still recommend-
ed and practised.[110-113] However, exercise could be delivered 
prior to surgery and serve as an adjunct treatment in the acceler-
ated perioperative care. In the 1990s the thought of offering 
rehabilitation through exercise to OA patients prior to TJA blos-
somed.[114-116] The idea of getting TJA patients ‘into shape’ 
prior to surgery later became popularly referred to as ‘prehabili-
tation’.[117]  Hypothetically, pre-operative exercise is associated 
with improvements in physical function prior to surgery and 
during in-hospital stay but may also contribute to post-operative 
recovery.[118, 119] One theoretical model just to justify pre-
operative exercise is presented in Figure 5. In theory, by improv-
ing physical function prior to surgery and otherwise following the 
known path with an immediate drop in physical function post-
operatively, patients may achieve a higher level of physical func-
tion and/or an earlier onset of recovery.[119] 
 
 
 
A systematic review found early studies to include insufficient 
numbers of patients and one to be confounded by the interven-
tion group receiving both pre- and post-operative exercise thera-
py.[120] Additionally, the heterogeneity of the interventions 
applied prevented pooling of the results.[121] However, there 
was some evidence to suggest clinically important differences 
between groups and reduced length of in-hospital stay.[120, 121] 
Since publication of the two systematic reviews, several random-
ised controlled trials (RCTs) have evaluated the effects of pre-
operative exercise.[119, 122-125] In 2011, one meta-analysis 
concluded there was moderate evidence to show that pre-
operative exercise reduces pain prior to total knee arthroplasty 
(ES, 95% CI: 0.43, 0.13 to 0.73) and improves physical function 
prior to total hip arthroplasty (ES, 95% CI: 0.47, 0.11 to 0.83) .126 
Furthermore, there is moderate evidence that pre-operative 
exercise and education programmes improves physical function 3 
weeks after total hip arthroplasty (ES, 95% CI: 0.53, 0.09 to 
0.9).126 A low to moderate effect on pain reduction prior to 
surgery (hip and knee) and a moderate effect on self-reported 
physical function (hip) post-operatively may potentially be out-
weighed by the pain relief from surgery. These beneficial post-
operative effects of self-reported physical function are in contrast 
to the conclusion drawn in the latest review by Hoogeboom et 
al.[126] where no effect of pre-operative exercise was found on 
post-operative functional recovery. Potential benefits may have 
been hampered by poor therapeutic validity of the exercise pro-
grammes evaluated in the included trials.[126] In summary, the 
knowledge of the role of pre-operative exercise in joint arthro-
plasty is based on a limited number of studies with small numbers 
of enrolled patients, heterogeneous interventions with low ther-
apeutic validity and few studies evaluating the cost-effectiveness 
of implementing such interventions.126,127  
 
AIMS OF THIS DISSERTATION 
General 
The overall aim was to evaluate the efficacy of a well described 
neuromuscular exercise programme when delivered to patients 
with severe symptomatic OA prior to joint arthroplasty of the hip 
or knee. 
Specific 
To determine the intra-rater reliability and agreement for maxi-
mal leg muscle power and several functional performance 
measures in patients with severe OA of the hip or knee joint. 
(Paper I) 
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To evaluate the immediate efficacy of an 8-week neuromuscular 
exercise programme in patients with severe osteoarthritis of the 
hip or knee joint. (Paper II) 
To study the 3-month post-operative effects of a neuromuscular 
exercise programme delivered prior to joint arthroplasty in pa-
tients with severe OA of the hip or knee joint. (Paper III) 
To determine potential differences in treatment effects between 
patients with hip and knee OA. (Papers II and III) 
 
 
 
METHODS 
Participants 
A total of 185 patients were included in the studies, Figure 6. 
All had symptomatic and severe radiographic hip or knee OA and 
were scheduled for joint arthroplasty. Inclusion criteria were kept 
wide to reflect daily clinical practice and are listed alongside 
exclusion criteria in Table 1. Patient characteristics for the pa-
tients included in the respective papers are listed in Table 2. 
 
 
 
The recruitment procedure differed for the two cohorts. 
 
The Reliability Cohort (Paper I) 
Eligible patients were scheduled for primary unilateral total hip or 
knee arthroplasty due to symptomatic OA at the Svendborg Hos-
pital, Odense University Hospital, Denmark. A complete list of 
patients on the waiting list was generated by a secretary. The 
patients were contacted consecutively (top down) until 20 pa-
tients were included.  Information on the study aim and proce-
dure was given over the telephone by the author and again on 
first contact. Informed written consent was obtained on the first 
test day.  
Recruitment took place from 1 November 2010 to 18 December 
2010. In total, 32 patients were contacted. 
 
The RCT Cohort (Papers II-III) 
Eligible patients were scheduled for primary unilateral total hip or 
knee arthroplasty due to symptomatic OA at the Svendborg Hos-
pital, Odense University Hospital, Denmark. Patient interest and 
eligibility were screened by the author via telephone and patient 
records. Written information about the study was given to the 
participants in the clinic by the surgeon scheduling the surgery. 
The surgeon was not otherwise involved in the study. Informed 
written consent was obtained on the day of baseline testing.  
Recruitment took place from 4 January 2010 to 21 March 2011. In 
total, 628 patients were screened and 499 patients met the inclu-
sion criteria. There is a treatment guarantee in the Danish Health 
Care System that one will be operated on within one month of 
being scheduled for TJA.  Entering this study meant that all pa-
tients accepted an additional waiting time of up to 5 weeks in 
comparison with the treatment guarantee. One hundred and five 
patients (21% of those eligible) were unwilling to wait longer for 
surgery and 108 patients (22% of those eligible) were unwilling to 
participate due to logistical constraints such as travelling distance 
or lack of transportation. After randomisation, the additional 
waiting time applied only to patients randomised to the exercise 
intervention. Of the eligible patients, 165 (33%) (81 with knee OA) 
were included and underwent randomisation, Figure 11.   
 
Intervention 
Participants in the intervention group (Papers II and III) received a 
basic educational package (described below in detail for the 
control group) in addition to attending a neuromuscular exercise 
programme for approximately 8 weeks. Neuromuscular Exercise 
in Total Joint Replacement (NEMEX-TJR) is a physiotherapist-
supervised, individualised and goal-based exercise programme. It 
has been demonstrated to be feasible in elderly people with 
severe knee and hip OA in terms of self-reported pain, decreased 
or unchanged pain during training, and progression in level of 
training.[64] The exercise programme was adopted in full from 
the original paper and the author, together with the supervising 
physiotherapist, participated in a training session and half a day 
of discussions with the developers of the programme in Lund, 
Sweden to ensure the programme would be carried out in ac-
cordance with the original intentions. The training programme is 
open access and available online as an additional file to the origi-
nal publication.[127] Briefly, it consists of a short warm-up (10 
minutes) on a stationary bike followed by a circuit programme (40 
minutes) and a cooling-down (10 minutes with walking, stretching 
and mobility exercises). Neutral alignment (‘knee over foot’) is 
emphasised throughout the programme. The circuit programme 
comprises four main focus areas: core stability/postural function, 
functional alignment of hip/knee, lower limb muscle strength and 
functional exercises. Each focus area comprises several exercises. 
The quality of the performance in each exercise is emphasised 
and the level of training and progression is guided by the patient's 
neuromuscular function evaluated by the supervising physiother-
apist. The programme was delivered twice a week. We stated a 
priori that attendance at 12 exercise sessions (out of a possible 16 
to 18, depending on the week day the patient joined the training) 
was considered good compliance. 
The control group (Papers II and III) received only the educational 
package, which consisted of written information about the oper-
ating procedure, expected postoperative progress and a leaflet on 
various exercises targeting range of motion and dynamic stability 
which was handed to them when scheduled for total hip or knee 
arthroplasty. One week prior to surgery patients participated in a 
3-hour in-clinic information session led by health professionals. 
No limitations were imposed on either group with regard to 
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changing exercise habits or seeking out other treatment during 
the study period. 
Post-operative rehabilitation was offered to all patients within 
their municipality. The duration and intensity varied, which is why 
we stratified for municipality.[128] 
 
 
 
Outcomes 
Outcomes were chosen to reflect the impairments experienced 
by patients with OA. These impairments fit well under the Inter-
national Classification of Functioning, Disability and Health 
(ICF).[1] The ICF is a framework to describe the dynamic interac-
tion between the health conditions (body function/structures, 
activity and participation) and contextual factors (environment 
and personal), Figure 7. OA can lead to impairments in body 
function (e.g. muscle weakness and pain), impairments in body 
structure (e.g. joint space narrowing and mal-alignment), activity 
limitation (e.g. reduced walking distance and difficulties perform-
ing daily activities) and participation restrictions (e.g. difficulties 
with participating in social activities). For this dissertation, the 
focus was on body function and activity limitations evaluated by 
means of self-reported questionnaires, functional performance 
and muscle function measures. 
Self-reported (Primary and secondary outcomes) 
The primary outcome in the RCT was the Activity of Daily Living 
(ADL) subscale on the Hip disability and Osteoarthritis Outcome 
Score (HOOS) and the Knee Injury and Osteoarthritis Outcome 
Score (KOOS) for patients with hip and knee OA, respective-
ly.[129-131] The HOOS and KOOS are disease-specific question-
naires and include the Western Ontario and McMasters Osteoar-
thritis Index (WOMAC) 3.0, a widely used questionnaire within 
the field of OA.[132] In addition to the subscales of Pain, Symp-
toms and ADL, which include the WOMAC items, the KOOS and 
HOOS also hold subscales assessing Sport and Recreation Func-
tion and joint-related Quality of Life. The ADL subscale contains 
17 items where patients rate the level of difficulty by answering 
on a 5-point Likert Scale from ‘None’ to ‘Extreme’. Secondary 
outcomes were the HOOS/KOOS Pain, Symptoms, Sport & Recrea-
tion and joint-related Quality of Life subscales. The HOOS and 
KOOS subscale scores are transformed to scores from 0 to 100 
points with higher scores indicating fewer joint-related problems.  
To assess health-related Quality of Life, the EuroQol 5-Dimension 
Health Questionnaire (EQ5D), a widely used generic self-
administered instrument, was used.[133, 134]. EQ5D consists of 
two pages: the EQ5D descriptive system and the EQ5D visual 
analogue scale (VAS). The descriptive system holds 5 dimensions: 
mobility, self-care, usual activity, pain/discomfort and anxie-
ty/depression, and is scored as the EQ5D index from 0 to 1. ‘0’ 
represents worse health state and ‘1’ represents full health state 
in the 5 dimensions. The EQ5D VAS records the respondent’s self-
rated health on a vertical, visual analogue scale with end-point 
‘Best imaginable health state’ (100) and ‘Worst imaginable health 
state’ (0).[135] 
Functional performance (exploratory outcomes) 
Measures of quantitative physical function are necessary to fully 
describe the disability experienced by OA patients and are rec-
ommended outcome measures in OA trials.[136, 137] We chose 
to include chair stands (i.e. 5 repeated chair stands timed at 
maximal velocity) and 20-meter walk tests (both 20-m walk at 
self-chosen pace and at maximal velocity) to reflect activities 
performed daily. Furthermore, unilateral knee-bending (i.e. max-
imal number of knee-bends performed in 30 seconds) was includ-
ed to reflect unilateral muscle strength and coordination.[138] 
Muscle function (exploratory outcomes) 
Muscle power (force exerted x velocity of the exertion) describes 
functional capacity more precisely than isometric and isokinetic 
variables in older healthy individuals.[139-143] However, little is 
known of muscle power in patients with OA.[144] We wanted to 
evaluate both isolated (single-joint) and integrated (multi-joint) 
muscle function in this patient group by means of dynamic maxi-
mal leg muscle power. Specific muscle groups, i.e. knee-
extensors, hip-extensors and hip-abductors, were examined by 
connecting a linear encoder to standard resistance exercise 
equipment and determination of peak power was subsequently 
made from the force-velocity relationship by commercial soft-
ware (MuscleLab Power, Ergotest Technology, Langesund, Nor-
way), Figure 8. Multi-joint leg extension power was measured in 
the so-called Nottingham Power Rig (NPR) (Nottingham Universi-
ty, Nottingham, UK), a commercially available leg extension press, 
Figure 9.[145]  
The outcomes evaluated in the two cohorts are listed in Table 3. 
 
Specifics for the reliability study (Paper I) 
Participants underwent a test-retest setup with testing on 
two separate occasions with approximately one week in between. 
Testing conditions were standardised (i.e. time of day, settings on 
exercise machines). No limitations to the patient’s daily activities 
prior to, or in between, test sessions were imposed. Testing was 
preceded by a 5-minute warm-up on a stationary exercise bike 
with low resistance (equal to a self-reported intensity of 3-6 on 
the Borg-scale). For unilateral tests, the ‘unaffected’ leg was 
tested first and the ‘affected’ leg tested last. The test battery was 
conducted in the following order: functional performance (20-m 
walks, chair stands and one-leg knee bends) and leg muscle pow-
er (multi-joint leg extension and single-joint knee extension, hip 
extension and hip abduction). 
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RANDOMISATION AND BLINDING (Papers II-III) 
The methodology in the study protocol was inspired by, and the 
manuscripts written in accordance with, the CONSORT-statement, 
the generally accepted procedure when reporting RCTs.[146-148] 
Allocation was conducted by the author after baseline assess-
ment using sequentially numbered, opaque, sealed envelopes. 
The allocation sequence was stratified by gender and municipali-
ty, and blocked in groups of four to allow for similar recruitment 
rates into both groups. The sequence and envelopes were pro-
duced by a person not otherwise affiliated with the trial. The 
allocation was performed either with the patient present or over 
the telephone. 
We did not consider it realistic to blind the participants to the 
group allocation. Four assessors conducted the physical testing 
and all underwent the same laboratory training. Allocation con-
cealment was attempted by instructing the patients not to reveal 
group allocation to the assessor. The post-intervention assessors 
had no access to previously obtained data. 
 
ETHICS APPROVAL AND STUDY REGISTRATION 
The Regional Ethics Committee of Southern Denmark approved 
the study protocol, layman study information was sent to the 
participants along with the written consent form and information 
on the individual’s rights regarding participation; approval num-
ber S-20090099. The randomised controlled trial was registered 
with ClinicalTrials.gov; identifier: NCT01003756. 
 
STATISTICAL ANALYSIS 
Reliability study (Paper I) 
The chosen sample of 20 participants was based upon recom-
mendations of sample size for reliability studies.[149] coefficient 
of variation (CVws) was used as a measure of agreement to de-
scribe the measurement error[150] and expressed as a percent-
age of the standard deviation to the group mean difference.[151] 
Minimal detectable change at the 90% confidence level (MDC90, 
also a measure of agreement) was calculated according to the 
following method[152]: MDC90 = SDtest-retest x 1.65  based on 
MDC90 = SEM x 1.65 x √2, where SEM = SDtest-retest/√2.[150] A 
change greater than the MDC90 is often interpreted as a true 
change on a personal level,[153] whereas CVws is unitless and 
makes variables comparable. 
Intraclass correlation coefficients (ICCconsistency) were calculat-
ed as a single measure of reliability to reflect between-patient 
variability.[150] The calculation is based on a mixed effect model 
with the listed parameter as the response variable and age, sex, 
weight, number of previous lower limb total joint arthroplasties, 
and joint operated on (hip or knee) as the exposure variables. A 
maximum likelihood estimate was used and ICC was calculated as 
patient variability divided by patient plus the residual variability. 
No interaction terms were included. There is no consensus on 
cut-points for ICCs. We applied the cut offs suggested by Landis et 
al.: no agreement (0), some (0-.20), fair (.21-.40), moderate (.41-
.60), good (.61-.80) and excellent (>.81).[154]  Graphs of the 
mean plotted against the difference of test minus retest results 
with 95% limits of agreement (LOA) (e.g. mean difference (test-
retest) ± 1.96xSD) were made for simple evaluation of heterosce-
dasticity and systematic bias.[153] A conservative approach to 
describe outliers as more than 3 SD of the mean was chosen[155]  
and subsequently omitted from further analysis.  
Randomised controlled trial (Papers II-III) 
Seventy-four patients were needed to detect a clinically relevant 
change of 10 points on the HOOS/KOOS ADL subscale (SD 15, 
power = .80 and α = .05). To allow for separate analysis of pa-
tients with knee OA and hip OA, 74 patients with knee OA and 74 
patients with hip OA were needed. To allow for around 10% loss 
to follow up, we decided to include 160 patients in total. 
A statistical analysis plan including all assessment points was 
outlined, allowing evaluation at 3 months after surgery and im-
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provement from baseline to 3 months after surgery in the same 
analysis. The plan was developed prior to code-breaking the 
allocation sequence. Data for primary and secondary outcomes 
were analysed according to the intention-to-treat principle with 
the baseline observation carried forward in cases where data 
were missing.[147] To evaluate the effects of the intervention, 
HOOS/KOOS subscales were analysed using analysis of covariance 
(ANCOVA) (Paper II) and a multilevel repeated-measures random 
effects model with change value as the response variable and 
baseline value, group, joint and time as covariates (Paper III). All 
interaction terms of group, joint and time were included and a 
maximum likelihood estimate was used (Paper III). Data from all 
assessed time points were included (Paper III). This one statistical 
model holds all between-group comparisons at all assessment 
points and allows for evaluation of the average effect over the 
time period from baseline to 3 months post-operatively. Data for 
functional performance and maximal muscle power (exploratory 
outcomes) were analysed as observed (baseline observation not 
carried forward) by analysis of covariance.  
Based on patients who improved 15% or more[156], the number 
needed to treat was calculated using the formula: 1/(EER - CER) 
where EER was the event rate in the exercise group and CER in 
the control group (Paper II).[157]  Standardised mean differences 
(SMD, effect size) were calculated for the subscales ADL and Pain 
to allow for comparison across studies. 
All p-values and 95% confidence intervals (95% CI) are reported as 
2-sided; p-values < 0.05 were considered statistically significant. 
Statistical analyses in Papers II and III were done by the project 
statistician who was masked to group allocation and the joint 
affected. The SAS statistical package (version 9.2; SAS institute 
Inc., Cary, NC, USA) and Stata 11 (Stata Corp., College Station, 
USA) were used for statistical models.  
 
SUMMARY OF RESULTS 
Agreement and Reliability of Functional Performance and Mus-
cle Power (Paper I) 
A statistically significantly better retest value (indicating a learn-
ing effect) was observed for four of the tests: 20-m walk at maxi-
mal pace, chair stands, unilateral knee bending and leg extension 
press. This learning effect is illustrated in Figure 10 where the 
confidence interval does not contain the value 0. Furthermore, 
No heteroscedasticity (tendency towards a greater difference, the 
larger the mean – ‘trumpet shape plot’) was observed, Figure 10. 
Agreement. For single-joint and multi-joint maximal peak power 
and functional performance measures, we demonstrated poor 
(CVws~25%, single-joint hip extension), moderate (CVws~15% , 
multi-joint leg extension press, single-joint knee extension, chair 
stands and knee bending) to good (CVws < 10% , single-joint knee 
flexion, single-joint hip abduction and 20-m walk) agreement. The 
minimal detectable change ranged from 6.0% to 59.7% for the 20 
meter walk at maximal pace and single-joint hip extension, re-
spectively. 
Reliability. We demonstrated good (ICC: .61-.80, single-joint hip 
extension, multi-joint leg extension press and knee bending) to 
excellent (ICC >.81, single-joint knee extension, knee flexion, hip 
abduction, 20-m walk and chair stands) reliability.  
An increase in VAS pain was reported after performance of 
the test battery compared with that prior to testing. After the first 
test session, this increase was insignificant (mean difference 4 
mm, p = .2876). A slightly higher increase, of doubtful clinical 
significance, was observed after the retest session (mean differ-
ence 11 mm, p = .0005) 
 
 
 
Recruitment and patient characteristics in the RCT (Papers II and 
III) 
The 334 patients unwilling to participate were, on average, 4 
years older (95% CI 2.3 to 5.6), 58% had hip OA and 60% were 
women. The 165 patients randomised to the two groups were, on 
average, 67±8 years, 84 (51%) had hip OA and 92 (56%) were 
women. The intervention group attended a mean of 13±5 exer-
cise sessions and all patients, in both groups, received the folder 
containing educational material. Of the 84 patients in the inter-
vention group, 62 attended the pre-specified goal of 12 or more 
exercise sessions indicating good compliance. One hundred and 
fifty-three patients attended the pre-operative 3-hour infor-
mation session and underwent surgery. Of the 81 patients with 
knee OA, 5 (3 in the exercise group) were re-scheduled and re-
ceived a uni-compartmental implant. Three patients were diag-
nosed with cancer, one with polymyalgia and one with a defective 
heart valve. One patient with both hip and knee OA was re-
scheduled from THA to TKA. One patient from the control group 
was re-evaluated and found to be ineligible for surgery. Finally, 
one patient felt markedly better after the exercise intervention 
and postponed surgery and, however regrettably, declined fur-
ther participation. 
Figure 11 depicts recruitment and flow of patients through 
this trial. 
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Neuromuscular exercise in patients with severe OA of the hip or 
knee (Paper II) 
The median time from baseline to post intervention (pre-
operative) assessment was 8.6 weeks (inter-quartile range (IQR) 
8.0 to 9.4 weeks) in the intervention group and 5.1 weeks (IQR 3.6 
to 6.9 weeks) in the control group.  
 
Primary and secondary outcomes 
For the primary outcome, HOOS/KOOS ADL subscale, the differ-
ence in mean change between groups was 7.2 points (95% CI 3.5 
to 10.9, p = .0002) in favour of NEMEX-TJR compared with the 
control. Likewise for the secondary outcomes of Pain, Symptoms, 
Sport and Recreation Function and Joint-Related Quality of Life, 
the mean differences were 5.3 (95% CI 2.1 to 8.4, p = .0012), 3.8 
(95% CI 0.3 to 7.3, p = .0358), 4.5 (95% CI 0.4 to 8.7, p = .0329) 
and 5.6 (95% CI 1.9 to 9.3, p = .0034) points, respectively, Figure 
12.  
Patients with hip OA reported greater improvement in physical 
function and reduction in pain than the patients with knee OA, 
shown by the significant effect of the interaction term joint  
group (p = 0.0497 and p = 0.0544 for the ADL and Pain subscales 
respectively). The difference between groups in HOOS/KOOS ADL 
scores showed improvement in favour of the intervention group 
of 10.9 for the hip OA patients (95 % CI 5.8 to 15.9) and 3.5 for 
the knee OA patients (95 % CI 1.8 to 8.8).  
On the basis of 15% improvement in ADL, the number needed to 
treat was 7 (4 and 23 for patients with hip and knee OA, respec-
tively. For ADL and Pain, we found moderate effect sizes in pa-
tients with hip OA (0.63, 95 % CI 0.26 to 1.00 and 0.57, 95 % CI 
0.20 to 0.94) and low effect sizes in patients with knee OA (0.23, 
95 % CI -0.14 to 0.60 and 0.15, 95% CI -0.21 to 0.52).  
 
Exploratory outcomes 
There was a significant difference between the groups in favour 
of the intervention group in chair stands (1.9, 95% CI 0.9 to 3.0 
seconds), 20-m. walk self-chosen pace (0.9, 95% CI 0.0 to 1.8 
seconds) and maximal number of knee bends on the index leg (leg 
to undergo surgery) (3.3, 95% CI 1.0 to 3.9 seconds). In the leg 
muscle power variables, we found statistically significant differ-
ences in single-joint hip abduction on the index leg (3.9, 95% CI 
0.1 to 7.8 Watts) and in multi-joint leg extension on the contra 
lateral side (10.1, 95% CI 0.8 to 19.3 Watts) in favour of the inter-
vention group. 
 
 
 
Postoperative effects of neuromuscular exercise prior to 
hip and knee arthroplasty (Paper III) 
Median time from baseline to surgery was 9.6 weeks (inter quar-
tile range from 8.9 to 10.7 weeks) in the intervention group and 
7.1 weeks (inter quartile range from 6.1 to 8.1 weeks) in the TJA 
only group. 
 
Hip versus knee OA 
We found no effect over time depending on the joint affected 
(hip or knee) demonstrated by a non-significant value of the 
interaction term time×joint×group (p-value = 0.4639). That is, the 
additional effect of exercise seen over the whole time period, 
baseline to 3 months post-operatively did not differ between 
patients with hip or knee OA, Figure 13A. However, the main 
effect of the explanatory variable Group was highly significant (p-
value = 0.0029) indicating an effect of exercise seen over the time 
period.  With no interaction of joint×group (p = 0.7370) seen, the 
approach of ignoring the affected joint is acceptable, Figure 13B. 
The results are thus given for all patients together, regardless of 
their having hip or knee OA. 
 
Efficacy analysis 
6 weeks after surgery 
Both groups improved at 6 weeks post-operatively, Figure 13. The 
intervention group demonstrated a statistically significant greater 
improvement in ADL (p = 0.0488) and Pain (p = 0.0472) than did 
the control group (difference between group means 5.6, 95% CI 
0.03 to 10.3 and 5.4, 95% CI 0.1 to 10.8, respectively), Figure 13B. 
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We found no statistically significant differences between groups 
in the HOOS/KOOS subscales Symptoms, Sport & Recreation and 
Joint-related Quality of Life.  
Patients in the intervention group reported significantly greater 
improvement in self-reported general health measured with the 
EQ5D VAS (difference between group means 7.6, 95% CI 2.1 to 
13.0).  
 
Three months after surgery – Primary end-point 
For the primary outcome ADL, we found no statistically significant 
difference between the two groups (4.4, 95% CI -0.8 to 9.5) at 3 
months after surgery, Figure 13B. As for the primary outcome, all 
secondary outcomes displayed a tendency towards favouring 
exercise over control, e.g. Pain: 4.5, 95% CI -0.8 to 9.9; however, 
none were statistically significant. Additionally, there was no 
difference in self-reported general health measured with the 
EQ5D between the two groups. 
Of the exploratory outcomes, i.e. functional performance and 
maximal muscle power evaluated only at 3 months post-
operatively, single-joint hip extension on the non-operated (8.4 
W, 95% CI 0.2 to 16.6) and single-joint hip abduction on both the 
operated and non-operated (8.0 W, 95% CI 2.4 to 13.6 and 7.1 W, 
95% 1.6 to 12.7) sides displayed statistically significant differences 
in favour of the intervention group. For all other exploratory 
outcomes, no differences were found. 
 
 
 
 
 
Adverse events 
Two patients from the control group, one with hip and one 
with knee OA, developed a deep peri-prosthetic infection and had 
the prosthetic components removed prior to the 6-week post-
operative assessment, Figure 11. 
 
GENERAL DISCUSSION 
Main findings 
This dissertation is based on the findings from three studies inves-
tigating reproducibility of quantitative measures of physical func-
tion (Paper I) and the effects of neuromuscular exercise in pa-
tients with severe symptomatic OA undergoing total hip or knee 
arthroplasty (Papers II and III). 
The evaluated test-battery comprising functional performance 
and muscle power measures demonstrated moderate to good 
agreement (that is, how close repeated measures are, within 
patient variability) and good to excellent reliability (that is, the 
parameter’s ability to distinguish between patients, between 
patient variability). To assist clinicians in future interpretations, 
minimal detectable changes were calculated for the individual 
tests (Paper I). Attending an 8-week exercise programme, previ-
ously found to be feasible, improved self-reported physical func-
tion, objective functional performance and reduced pain prior to 
surgery. The effect seemed greater in patients with hip OA com-
pared with knee OA (Paper II). At 3 months postoperatively (pri-
mary endpoint), no additional benefits were seen from the pre-
operative exercise. Seen over the entire time period, from 
baseline to 3 months after surgery, the adjunct of exercise result-
ed in an earlier onset of postoperative recovery in self-reported 
activities of daily living (ADL) and pain relief compared with the 
standard TJA procedure. Although no statistically significant dif-
ferences were observed at 3 months after surgery, the statistical-
ly significant differences in ADL, Pain and QoL at 6 weeks postop-
eratively support the greater overall improvement seen from 
baseline to 3 months postoperatively for the intervention group. 
Overall, the treatment effects of pre-operative exercise in combi-
nation with TJA were not more beneficial for THA patients than 
for TKA patients (Paper III).  
 
 
Methods and material 
Design: 
To evaluate the effects of an intervention, a randomised con-
trolled trial is considered the method of choice. We conducted a 
randomised, controlled trial according to the CONSORT-
statement (the gold standard for RCT reporting)[146-148] with a 
rigorous study design and an adequate sample size to allow for 
separate analysis for hip and knee OA patients. 
Patients: 
The inclusion criteria were kept broad to reflect the daily clinical 
practice as seen by the wide age range (43 to 89 years).  The 
exclusion criteria applied were to ensure a representative group 
with regard to the disease in question. Of the population sched-
uled for THA and TKA, only 16% were excluded. Despite succeed-
ing in including a higher proportion of eligible patients than in 
similar studies, we still only included 30% of those eligible, which 
diminishes the external validity of the study. The low inclusion 
rate was mostly due to the one-month treatment guarantee in 
the Danish Healthcare system and the fact that the intervention 
was offered at only one location, circumstances that were beyond 
our control but may nevertheless have introduced a selection 
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bias. The 334 patients unwilling to participate were, on average, 4 
years older and more were of the female sex than the patients 
included. Unfortunately, little else is known about these patients, 
e.g. their level of pain experienced and physical function. Howev-
er, the recruitment rate is higher than similar trials, e.g. Rooks et 
al. (12%)[123], where the surgical treatment and the surgeons’ 
reputation attract patients from a wide geographic area. General-
ly, unwillingness to participate may reside in the fact that patients 
tend to seek out treatment when symptoms are at their worst.  
Intervention: 
The exercise interventions applied in OA research are heteroge-
neous which makes comparison across studies challenging.63,126 
Furthermore, the interventions may lack therapeutic validity 
which affects the clinical efficacy.[126] For this dissertation, a 
feasible and safe intervention was chosen. The neuromuscular 
exercise intervention is well described, focuses on the quality of 
the performance in each exercise and is individualised and pro-
gressed through therapist supervision.[64] It aims at achieving 
dynamic stability through coordinated muscle activity, which is 
essential for everyday voluntary movement. It is therefore en-
couraging to observe significant effects on the patient’s percep-
tion of activities of daily living alongside improvement in func-
tional performance (Paper II). 
Outcomes: 
Outcomes were chosen to reflect the impairments experienced 
by patients with OA. It is generally recommended to use patient-
reported outcomes as primary outcomes in clinical trials.[137, 
158, 159] However, it is suggested to include functional perfor-
mance measures to fully cover the patient’s disability.[136, 160] 
Both the self-reported and the performance measures chosen for 
this study are easily administered and require little time, making 
them feasible to use in trials with a larger number of enrolled 
participants. We included a test-battery of functional perfor-
mance measures and specific single-joint and multi-joint muscle 
tests to complement patient reports and possibly serve as ex-
planatory factors for observed differences between 
groups.162Muscle power (force exerted x velocity of the exer-
tion) has been shown to describe functional capacity more pre-
cisely than isometric and isokinetic variables in older healthy 
individuals.[139-143, 161].  The apparatus and software used in 
the evaluation of muscle power was easy to handle and demon-
strated acceptable reliability and agreement, however the proce-
dure was rather time-consuming and cannot be recommended 
for large scale RCTs or cohort studies. 
  
Exercise in patients with patients with severe symptomatic OA 
Today, it is generally accepted that exercise can reduce pain 
and improve physical function in patients with mild to moderate 
symptoms of knee OA[41] and thus constitutes one of the core 
treatments for OA, Figure 14.[70, 162] 
Little, however, is known of the effects in patients with severe 
OA. I am un-aware of any studies evaluating the effects of exer-
cise in this patient group unless derived from data obtained pre-
operatively with the exercise intervention as adjunct to surgical 
treatment. We too used patients scheduled for surgery as a mod-
el of severe symptomatic OA (Paper II). The significant improve-
ments in both ADL and Pain were demonstrated alongside im-
provements in functional performance and muscle power, making 
the exercise intervention the probable cause. Furthermore, we 
found indications that the neuromuscular exercise was more 
effective in patients with hip OA. One could argue that part of the 
difference between the two groups was caused by a small deteri-
oration in the control group which amplified the potential ‘true’ 
difference (Table 2, Paper II). A true deterioration in the control 
group is unlikely due to the short time awaiting surgery. This was  
 
 
 
supported by previous research which indicates no deterioration 
in up to 3 months while waiting for surgery.[163] If the deteriora-
tion is caused by disappointment at not being allocated to the 
intervention group, this is unknown. It is possible that the further 
attention received in the intervention group may have affected 
the results, but one would expect this to apply to only the self-
reported outcomes. Again, we observed concurrent improve-
ments in functional performance which support a true overall 
improvement. 
 
Preoperative exercise as adjunct treatment to joint arthroplasty 
We aimed to improve ADL and reduce pain postoperatively by 
adding a clinically feasible neuromuscular exercise programme as 
an adjunct treatment prior to THA and TKA surgery. Despite a 
greater mean change favouring exercise, our results demonstrat-
ed no statistically significant difference in effect for preoperative 
exercise at 3 months after surgery. However, when considering 
improvement from baseline to 3 months postoperatively, neuro-
muscular exercise therapy was associated with greater overall 
improvement and earlier onset of postoperative recovery. Taking 
part in a pre-operative exercise programme enabled the partici-
pants to reach the level of ADL improvement seen in the surgery 
only group at 12 weeks some 6 weeks earlier. This earlier im-
provement may be valued by some patients, their surgeons and 
other decision-making stakeholders. 
The findings in this trial are in line with that of a recent systematic 
review and meta-analysis demonstrating short-term postopera-
tive effects of exercise undertaken prior to TJA by patients with 
severe OA.126 In contrast to previous studies with suggested 
poor therapeutic validity of the exercise interventions[126] and 
little or no effect post surgery, the neuromuscular exercise inter-
vention used in this study was found to be effective immediately 
following the intervention (Paper II), indicating good therapeutic 
validity. The generally favourable effects seen in functional per-
formance and muscle power (Paper II) levelled out at 3 months 
after surgery. However, for hip abduction and hip extension, the 
improvements of up to 40% seen in the intervention group were 
statistically greater than in the control group. These movements 
were tested in a standing up-right position and it is conceivable 
that the intervention group felt more confident performing a 
maximal voluntary contraction. It is of particular note, however, 
that patients with hip OA from the intervention group, after a 
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recent surgical trauma and receiving an artificial joint, performed 
markedly better on the operated side at follow up than did con-
trols. Hip abduction and hip extension are important pre-
requisites for normal gait.[164-166] For quadriceps muscle func-
tion, known to be reduced in THA and TKA patients[167, 168], no 
effects of neuromuscular exercise were found. This is not surpris-
ing since this intervention is specifically targeting dynamic align-
ment and functional stability and not muscle power per se. This 
may partly explain the superior results for the exercise group in 
the tests performed in the standing position, since these require 
more core and lower limb stability. 
One-third of the participants in this study were less than 65 years 
of age and, hence, potentially still working. It is unknown if earlier 
onset of recovery was beneficial in terms of faster return to work. 
In future studies, return to work should be assessed in addition to 
other possible benefits from pre-operative exercises such as the 
need for in-patient and out-patient postoperative rehabilitation 
services.  
 
Differences in treatment effects between patients with hip and 
knee OA 
Previous findings of possible differences in effects of exercise 
between THA and TKA patients are conflicting. Some have found 
TKA patients to display a somewhat slower course of physical 
function and pain recovery than THA patients.[81, 169] In con-
trast, others argue a faster recovery of physical function after 
TKA.[87] This study was designed to allow for comparison of hips 
and knees. We have demonstrated that patients with hip and 
knee OA respond differently immediately after the exercise inter-
vention, showing greater benefit for the hip patients (Paper II). 
This pattern shifts postoperatively with knee patients demon-
strating a greater and statistically significant short-term effect in 
ADL (Paper III, Table 2, Figure 2A). The analysis from baseline to 3 
months after surgery demonstrated however no difference for 
hip and knee in the additional effect of exercise. Since all assess-
ment points were included in the longitudinal analysis model, a 
potentially greater postoperative benefit in TKA patients may be 
blurred by the favourable effects seen immediately after exercise 
in THA patients. Furthermore, the postoperative within-group 
improvements from baseline were generally greater for patients 
with hip OA. This was particularly clear for short-term (6 weeks) 
self-reported pain, where the statistically different (p=0.0060) 
within-group improvement for hip OA patients was above 30 
points, and for knee OA patients below 20 points. Also for phar-
macological treatment of pain in OA, differences have been 
demonstrated for hip and knee patients.[170]  
Whatever the exact course of recovery after TJA, this study adds 
to the body of evidence suggesting that different measures may 
need to be taken to individualise and optimise the treatment for 
patients with hip and knee OA.[41, 171]  
 
Strengths and limitations 
We conducted a randomised, controlled trial that was reported 
according to the CONSORT statement[146, 147] with a rigorous 
study design, adequate sample size to allow for separate analysis 
for hips and knees, and a clinically feasible and therapeutically 
valid intervention. Our study also has limitations. No measures 
were taken to comply with the possible risk of attention bias. 
However, treatments in the two groups did not differ from the 
day of hospital admission to follow-ups and we believe the poten-
tial risk of attention bias introduced during the preoperative 
exercise intervention to be minimal when outcomes were as-
sessed following surgery. Despite succeeding in including a higher 
proportion of eligible patients than in similar studies, we still only 
included 30% of those eligible, which diminishes the external 
validity of the study. The low inclusion rate was mostly due to the 
one-month treatment guarantee in the Danish Healthcare system 
and the fact that the intervention was offered at only one loca-
tion, circumstances that were beyond our control but may never-
theless have introduced a selection bias. 
The exercise intervention was consistent over the entire period, 
though it is uncertain as to whether or not the same results 
would be obtainable in a multiple-location setting. Blinding of 
assessors was attempted through patient discretion and re-
striction of access to previously obtained data. We did not meas-
ure the success of assessor blinding, however the primary and 
secondary outcomes were self-reported and thus not subjected 
to possible assessor bias. Delivering a placebo treatment would 
have been optimal but was not deemed realistic due to the na-
ture of exercise and the difficulty in designing a credible placebo 
intervention. 
 
CONCLUSION AND FUTURE IMPLICATIONS 
Preoperative neuromuscular exercise constitutes a viable adjunct 
therapy to hip or knee arthroplasty, which may be of interest to 
individual patients willing to engage in preoperative exercise to 
achieve an earlier onset of postoperative recovery. At 3 months 
however, the effects of preoperative exercise were no longer 
evident. 
We have demonstrated an effect from baseline to 3 months after 
surgery. Future studies will evaluate one-year postoperative 
efficacy and whether implementation of this new practice is cost-
effective. If so, it should be implemented and offered as part of 
the treatment to all patients undergoing total joint arthroplasty 
due to severe symptomatic OA of the hip or knee. Although eco-
nomic evaluations were  not a part of this dissertation, it is 
somewhat thought-provoking that most hospitalisation costs 
(ambulatory and hospital care) are allocated to hip and knee 
arthroplasties, and although they constitute a large proportion of 
total costs, they represent resources used by only 5% of the OA 
patients.[33] This should be seen in the light of the positive ef-
fects of non-pharmacological/non-surgical options in OA, e.g. 
patient education and exercise, described throughout this disser-
tation. 
The results from this dissertation bring forth new information to 
decision-making stakeholders and also question whether the 
clinically unfounded treatment guarantee of one month for total 
joint arthroplasty after being scheduled is reasonable and desira-
ble. Finally, I propose a more stringent clinical pathway in line 
with national and international evidence-based recommendati-
ons[22, 41, 162] to ensure patients with hip or knee OA receive 
core treatments and international standards of care prior to 
surgical options. This clinical pathway should include optimised 
non-surgical treatment including exercise and be offered 3 
months prior to the referral to the orthopaedic surgeon. 
 
SUMMARY 
Osteoarthritis (OA) is a degenerative joint disease affecting the 
whole joint and peri-articular structures like the muscles. The 
hallmark of OA is cartilage loss. The main symptoms are pain and 
decreased physical function leading to a reduced quality of life. 
OA ranks 8th in leading causes of disability worldwide and it 
generates a heavy economic burden for society. The prevalence 
of OA increases with age and 10-18% aged above 60 years are 
affected. Currently there is no cure for OA and the various treat-
 DANISH MEDICAL JOURNAL   13 
ment modalities aim at addressing symptoms, i.e. reducing pain, 
improving physical function and preventing further progression of 
the disease. Exercise has proven to be a viable treatment option 
with regard to reducing pain and improving physical function in 
patients with mild to moderate knee OA and is today regarded a 
cornerstone in the treatment. The documentation is less clear for 
hip OA. Patients with severe OA of the hip or knee are treated 
with total joint arthroplasty (TJA). Although, in general, it is a very 
successful procedure, there are still challenges to overcome in 
this patient group, as approximately 10% of those having hip 
arthroplasty and 20% of those having knee arthroplasty have 
persistent symptoms. The evidence on the efficacy of exercise 
prior to TJA is sparse. It is based on insufficiently powered trials 
and with interventions of questionable validity. Two recent sys-
tematic reviews and meta-analyses reach conflicting conclusions 
and highlight the need for high quality trials with sufficient sam-
ple sizes. 
 
In this dissertation, I wanted to evaluate the effects of an individ-
ualised neuromuscular exercise programme (NEMEX-TJR) when 
administered prior to joint arthroplasty in patients with severe 
OA of the hip or knee joint. This intervention was previously 
found to be feasible with regard to pain level during exercise and 
it was possible to progress the training level in this patient group. 
The main question asked was: Does the addition of neuromuscu-
lar exercise prior to TJA result in further improvement in self-
reported outcomes during the first 3 months? To answer this, a 
randomised controlled trial (RCT) enrolling patients with severe 
symptomatic OA scheduled for TJA was conducted. Self-reported 
ADL was the primary outcome of the trial and self-reported pain 
and quality of life were the main secondary outcomes. A test 
battery of three functional performance measures and four lower 
extremity muscle power tests was chosen to complement the 
questionnaires and to explore the physical function in these pa-
tients. 
In the first study, the test battery was evaluated with regard to 
agreement and reliability. Identification of the smallest detecta-
ble differences in the tests was needed to assist in the interpreta-
tion of the RCT results and aid clinicians in future evaluation of 
patients in their daily clinical practice. A cohort of 20 patients 
with severe symptomatic OA of the hip or knee (56-79 years, 50% 
women) was evaluated in the test battery on two occasions sepa-
rated by one week. We found that muscle power can safely be 
evaluated with poor to good agreement and good to excellent 
reliability. Hence, some measures (20 m walk, chair stands) are 
more reliable to detect change over time, e.g. longitudinal re-
search, whereas others may be useful in a daily clinical setting to 
evaluate to what extend the patient’s muscle function is affected  
(single- and multi-joint muscle power). Seen as a whole, the en-
tire test battery is time-consuming (1½-2 hours) and not suited 
for evaluation of larger cohorts.  
The enrollment of patients in the RCT began in January 2010. A 
cohort of 165 hip and knee OA patients (43-89 years, 56% wom-
en, 84 hip OA) was enrolled after approximately one year. This 
sample size would also allow stratified analysis, e.g. evaluation of 
possible differences in the treatment effect between hip or knee 
OA patients. The intervention group participated in an 8-week 
neuromuscular exercise programme prior to TJA in addition to the 
usual care (information leaflets and a 3-hour information session 
by health professionals) provided in Svendborg Hospital, Odense 
University Hospital, Denmark. Patients were assessed at baseline, 
one week prior to surgery, 6 weeks and 3 months after surgery 
(primary end-point). Two essential questions of interest were 
identified prior the development of the statistical analysis plan. 
Firstly: Does the addition of neuromuscular exercise prior to TJA 
improve the postoperative outcome? The initiation of rehabilita-
tion prior to surgery was thought to be of general interest to the 
health community. Secondly: What are the effects of neuromus-
cular exercise when evaluated as a treatment option for patients 
with severe osteoarthritis? This question is most likely to be of 
interest to health professionals with a specific interest in exercise 
rehabilitation and OA research. 
In the second study, the cohort served as a model for patients 
with severe OA (regardless of the following operation). Patients 
were evaluated immediately after the intervention (one week). 
We found that participation in neuromuscular exercise for 8 
weeks according to the NEMEX-TJR programme improves activi-
ties of daily living, objective functional performance, and quality 
of life and reduces pain in patients with severe osteoarthritis 
(OA). The effect is greater in patients with hip OA than in patients 
with knee OA. The study confirms previous findings from non-
randomised studies that neuromuscular exercise is feasible and 
safe for patients with severe OA 
In the third study, the efficacy of NEMEX-TJR as an adjunct treat-
ment to TJA was evaluated. At the primary end-point 3 months 
after surgery, there was no additional effect of an 8-week pre-
operative neuromuscular exercise programme in combination 
with total joint arthroplasty compared with total joint arthroplas-
ty alone. However, from baseline to 3 months after surgery the 
overall longitudinal improvements seen in physical function and 
pain were statistically significantly greater and occurred earlier 
after surgery in the intervention group receiving preoperative 
neuromuscular exercise compared with the control group receiv-
ing care-as-usual only. 
 
From this dissertation, I conclude that neuromuscular exercise 
according to NEMEX-TJR can serve as adjunct therapy to hip or 
knee arthroplasty of interest to individual OA patients willing to 
engage in preoperative exercise to achieve an earlier onset of 
postoperative recovery. At 3 months however, the effects of 
preoperative exercise are no longer evident.  Furthermore, for 
patients with severe OA of the hip joint, neuromuscular exercise 
may serve as a safe and viable treatment option with improve-
ment in ADL, functional performance and a reduction in pain. 
Whether implementation of this adjunct therapy in clinical prac-
tice is feasible and cost-effective remains to be evaluated. 
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